Backgrounds The presence of 5 circulating tumor cells (CTCs) in 7. first follow-up (= 0.029) and the number of therapies patients received before this study (= 0.006) were indie prognostic factors in terms of progression-free survival. The number of therapies (= 0.001) and a count of 5 183506-66-3 IC50 CTCs (= 0.043) at baseline were… Continue reading Backgrounds The presence of 5 circulating tumor cells (CTCs) in 7.